Weight loss results may vary among individuals depending on body mass index, genetics, lifestyle, dietary habits, and physical activity
The peptides for weight loss in women and safest peptides for women articles discuss how AOD 9604 fits into female-specific protocols, where hormonal sensitivity is often a primary concern
Research Considerations Outcomes may vary with diet, environmental conditions, and protocol design ERR agonist effects appear to be synergistic with concurrent exercise in animal models Compound handling and capsule storage should be standardized across a study Co-administration with other ERR-active or mitochondria-targeting compounds has not been characterized Administration SLU-PP-332 in the 250 mcg capsule form is taken orally
Symptoms include difficulty breathing, facial or throat swelling, rapid heartbeat, hives, and a sudden drop in blood pressure